Abstract:BackgroundWith increasing interest in natural orifice surgery, there has been a dramatic evolution of transanal and endoluminal surgical techniques. These techniques began with transanal endoluminal surgical removal of rectal masses and have progressed to transanal radical proctectomy for rectal cancer. The first transanal total mesorectal excision (taTME) was performed in 2009 by Sylla, Rattner, Delgado, and Lacy. The improved visibility and working space associated with the taTME technique is intriguing. This video manuscript outlines the training pathway followed by pioneers in the taTME technique, the process of implementation into clinical practice, and initial case report.MethodsA double board-certified colorectal surgeon with expertise in rectal cancer, minimally invasive total mesorectal excision, transanal endoscopic surgery (TES), and intersphincteric dissection, underwent taTME training in male cadaver models. Institutional review board (IRB) approval for a phase I clinical trial was achieved. The entire operative team including surgeons, nurses, and operative staff underwent taTME cadaver training the day prior to the first clinical case. The case was proctored by an expert in taTME.ResultsA 66-year-old male with uT3N1M0 rectal cancer located in the posterior distal rectum, underwent taTME with laparoscopic abdominal assistance, hand sewn coloanal anastomosis, and diverting loop ileostomy. The majority of the TME was performed transanally with laparoscopic assistance for exposure, splenic flexure mobilization, and high ligation of the vascular pedicles. Operative time was 359 min. There were no intraoperative complications. Pathology revealed a ypT2N1 moderately differentiated invasive adenocarcinoma, grade I TME, 1 cm circumferential radial margin, and 2/13 positive lymph nodes.ConclusionImplementation of taTME into practice can be achieved by surgeons with expertise in minimally invasive TME, TES, pre-clinical taTME training in cadavers, case observation, proctoring, and ongoing mentorship. IRB peer review process and participation in a clinical registry are additional measures that should be employed.

Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results

The application of laparoscopic total mesorectal excision with preservation of anal sphincter for rectal cancer

Transanal Total Mesorectal Excision for Rectal Cancer: a Multicentric Cohort Study.

Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results From the Phase II North American Multicenter Prospective Observational Trial

Oncologic outcomes following transanal total mesorectal excision: the United States experience

A Way to Start Transanal Total Mesorectal Excision for Rectal Cancer

Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results

Transanal total mesorectal excision: short- and long-term results of four certified colorectal cancer centers in Germany

Transanal Vs Laparoscopic Total Mesorectal Excision for Rectal Cancer: a Multicenter Randomized Phase III Clinical Trial (talar Trial) Protocol

Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer

Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients

Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer

Oncological monitoring after transanal total mesorectal excision (TaTME) for rectal neoplasia

Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom

The role of transanal total mesorectal excision in the treatment of rectal cancer: a systematic review

Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway

Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial

Transanal total mesorectal excision: Understanding indications, managing complications, and effective prevention methods

Long-term outcomes of transanal total mesorectal excision for rectal cancer: what could we do to improve them?

Transanal Total Mesorectal Excision for Rectal Cancer

A Prospective European Trial Comparing Laparotomy, Laparoscopy, Robotic-Assisted, and Transanal Total Mesorectal Excision Procedures in High-Risk Patients with Rectal Cancer: The RESET Trial